Related Experiment Videos
Changing T cell specificity by retroviral T cell receptor display
H W Kessels1, M D van Den Boom, H Spits
1Department of Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Summary
Researchers developed retroviral T cell receptor (TCR) display to create novel TCRs. This method generates potent TCRs beyond natural immune system capacity, useful for therapies like cancer treatment.
Area of Science:
- Immunology
- Molecular Biology
- Genetic Engineering
Background:
- T cell receptor (TCR) diversity is inherently limited by thymic selection processes.
- Existing TCRs may not recognize all desired antigens, necessitating methods to expand specificity.
Purpose of the Study:
- To develop a novel strategy, retroviral TCR display, for generating T cells with specificities beyond the natural immune repertoire.
- To demonstrate the utility of TCR display by creating and selecting influenza A-specific TCRs.
Main Methods:
- Generated a library of T cell variants in vitro.
- Introduced these variants into a TCR-negative murine T cell line via retroviral transfer.
- Selected TCRs with specificity for parental or altered influenza A epitopes.
Main Results:
- Successfully created a library of influenza A-specific TCRs using retroviral display.
- Selected TCRs demonstrated efficient T cell activation upon ligand recognition.
- In vitro selected TCRs exhibited potency equal to or greater than the original in vivo generated receptor.
Conclusions:
- Retroviral TCR display is a valuable strategy for generating T cells with novel specificities.
- This method can produce high-affinity TCRs for therapeutic applications, such as tumor-specific gene transfer.
- The approach overcomes limitations of natural T cell selection for therapeutic targeting.